Huihao Zhou

3.1k total citations · 1 hit paper
99 papers, 2.2k citations indexed

About

Huihao Zhou is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Huihao Zhou has authored 99 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Computational Theory and Mathematics. Recurrent topics in Huihao Zhou's work include RNA and protein synthesis mechanisms (26 papers), RNA modifications and cancer (23 papers) and Computational Drug Discovery Methods (14 papers). Huihao Zhou is often cited by papers focused on RNA and protein synthesis mechanisms (26 papers), RNA modifications and cancer (23 papers) and Computational Drug Discovery Methods (14 papers). Huihao Zhou collaborates with scholars based in China, United States and Norway. Huihao Zhou's co-authors include Qiong Gu, Jun Xu, Yuying Fang, Xiang‐Lei Yang, Qingyun Tan, Paul Schimmel, Xiu‐Cai Chen, Litao Sun, Jeffrey H. Chuang and Susan L. Ackerman and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Huihao Zhou

94 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1 Interaction: A New Mechanism of Action

2021 353 citations Yuying Fang, Qingyun Tan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huihao Zhou China	22	1.6k	365	345	207	169	99	2.2k
Nam Doo Kim South Korea	32	1.8k 1.2×	277 0.8×	200 0.6×	384 1.9×	230 1.4×	102	2.9k
Zunnan Huang China	26	1.6k 1.0×	652 1.8×	160 0.5×	320 1.5×	333 2.0×	116	2.6k
Yuling Qiu China	26	1.3k 0.8×	399 1.1×	241 0.7×	297 1.4×	44 0.3×	89	2.4k
Yingli Wu China	32	2.2k 1.4×	541 1.5×	213 0.6×	516 2.5×	59 0.3×	145	3.2k
Jung‐Il Chae South Korea	29	1.3k 0.8×	208 0.6×	113 0.3×	250 1.2×	80 0.5×	84	2.1k
Ganesha Rai United States	26	1.3k 0.8×	142 0.4×	104 0.3×	175 0.8×	163 1.0×	90	2.2k
Shinji Tsutsumi Japan	35	2.3k 1.5×	220 0.6×	183 0.5×	403 1.9×	218 1.3×	77	3.3k
Dexin Kong China	32	1.9k 1.2×	534 1.5×	216 0.6×	606 2.9×	79 0.5×	120	3.1k
Ping Chen China	31	2.1k 1.4×	728 2.0×	390 1.1×	838 4.0×	122 0.7×	125	3.3k
Dipak Datta India	30	1.1k 0.7×	287 0.8×	169 0.5×	691 3.3×	60 0.4×	84	2.5k

Countries citing papers authored by Huihao Zhou

Since Specialization

Citations

This map shows the geographic impact of Huihao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huihao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huihao Zhou more than expected).

Fields of papers citing papers by Huihao Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huihao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huihao Zhou. The network helps show where Huihao Zhou may publish in the future.

Co-authorship network of co-authors of Huihao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huihao Zhou. A scholar is included among the top collaborators of Huihao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huihao Zhou. Huihao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Peng, et al.. (2025). Structure-based design of tirabrutinib derivatives as inhibitors of bacterial tryptophanyl-tRNA synthetase. Bioorganic Chemistry. 165. 108978–108978.

Xu, Peng, et al.. (2025). Development of potent inhibitors targeting bacterial prolyl-tRNA synthetase through fluorine scanning-directed activity tuning. European Journal of Medicinal Chemistry. 291. 117647–117647.

Xu, Jun, et al.. (2024). Biochemical and structural characterization of chlorhexidine as an ATP-assisted inhibitor against type 1 methionyl-tRNA synthetase from Gram-positive bacteria. European Journal of Medicinal Chemistry. 268. 116303–116303. 3 indexed citations

He, Yingying, et al.. (2024). KIFC1 depends on TRIM37-mediated ubiquitination of PLK4 to promote centrosome amplification in endometrial cancer. Cell Death Discovery. 10(1). 419–419. 2 indexed citations

Fang, Yi, et al.. (2024). The mechanism of discriminative aminoacylation by isoleucyl-tRNA synthetase based on wobble nucleotide recognition. Nature Communications. 15(1). 10817–10817. 1 indexed citations

Han, Lu, Taotao Zou, Junjian Wang, et al.. (2023). The binding mode of orphan glycyl-tRNA synthetase with tRNA supports the synthetase classification and reveals large domain movements. Science Advances. 9(6). eadf1027–eadf1027. 12 indexed citations

Peng, Weiyu, Yajuan Feng, Shujie Liu, et al.. (2022). Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease. Small Science. 2(6). 2270012–2270012. 13 indexed citations

Peng, Weiyu, Yajuan Feng, Shujie Liu, et al.. (2022). Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease. SHILAP Revista de lepidopterología. 2(6). 2100124–2100124. 22 indexed citations

Fang, Yuying, Qingyun Tan, Huihao Zhou, Qiong Gu, & Jun Xu. (2022). Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents. European Journal of Medicinal Chemistry. 231. 114151–114151. 27 indexed citations

10.

Wu, Shuang, Junye Liu, Xue-Fei Cai, et al.. (2022). Release of hepatitis B virions is positively regulated by glucose‐regulated protein 78 through direct interaction with preS1. Journal of Medical Virology. 95(1). e28271–e28271. 5 indexed citations

11.

Han, Lu, et al.. (2021). X-shaped structure of bacterial heterotetrameric tRNA synthetase suggests cryptic prokaryote functions and a rationale for synthetase classifications. Nucleic Acids Research. 49(17). 10106–10119. 14 indexed citations

12.

Gu, Qiong, et al.. (2021). Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase. Nature Communications. 12(1). 1616–1616. 21 indexed citations

13.

Gu, Qiong, et al.. (2021). Author Correction: Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase. Nature Communications. 12(1). 2533–2533. 1 indexed citations

14.

Sun, Litao, Na Wei, Bernhard Kuhle, et al.. (2021). CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS. Proceedings of the National Academy of Sciences. 118(13). 19 indexed citations

15.

Xu, Hongjiao, Qian Zhao, Zhibin Yan, et al.. (2021). Author Correction: AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nature Communications. 12(1). 2036–2036. 2 indexed citations

16.

Pei, Hua, Chao Zhao, Huihao Zhou, et al.. (2020). Jatrophane Diterpenoids from Euphorbia esula as Inhibitors of RANKL-Induced Osteoclastogenesis. Journal of Natural Products. 83(4). 1005–1017. 16 indexed citations

17.

Guo, Junsong, Ying Yu, Bao Cheng, et al.. (2020). Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors. European Journal of Medicinal Chemistry. 207. 112848–112848. 11 indexed citations

18.

Zhang, Yuting, et al.. (2020). Discovery of ingenane and jatrophane diterpenoids from Euphorbia esula as inhibitors of RANKL-induced osteoclastogenesis. Fitoterapia. 146. 104718–104718. 6 indexed citations

19.

Ishimura, Ryuta, Gábor Nagy, Iván Dotú, et al.. (2014). Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science. 345(6195). 455–459. 328 indexed citations

20.

Liu, Yang, et al.. (2009). Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 65(7). 692–694. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact